Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Ardelyx, Inc.

< Previous 1 2 3 Next >
Ardelyx Announces Amendment of Debt Financing Agreement with SLR Capital Partners to Provide $50 Million of Additional Committed Capital
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Present Data Updates for XPHOZAH (tenapanor) for Hyperphosphatemia at Kidney Week 2023 November 1-5 in Philadelphia, PA
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Shares Preliminary Data on Use of IBSRELA® (tenapanor) in Pediatric IBS-C Patients at NASPGHAN 2023
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Tenapanor for Hyperphosphatemia Approved in Japan
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Present at the Jefferies 2023 Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces FDA Acceptance and Six-Month Review for Resubmission of its New Drug Application of XPHOZAH® (tenapanor)
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Presents Positive Data at DDW 2023 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Reports First Quarter 2023 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with IBS-C, to be Presented at the 2023 Digestive Disease Week Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Report First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Resubmits New Drug Application to U.S. Food and Drug Administration for XPHOZAH® (tenapanor)
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH® (tenapanor) at National Kidney Foundation 2023 Spring Clinical Meetings
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Publishes First Environmental, Social and Governance (ESG) Report
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Participate at the Cowen 43rd Annual Health Care Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.